Charles Homcy
Partner at Third Rock Ventures
San Francisco, California
Writes $100K – $5M checks · typically $1.5M
About
A physician with extensive experience building and leading biotech companies, focused on forming companies developing novel therapeutics. He has been a clinical professor at UCSF Medical School and an attending physician at the San Francisco VA Medical Center since 1997, and previously co-founded Portola Pharmaceuticals, serving as its president and CEO.
Invests in
Biotech
Deals · 3
Faze MedicinesBoard seat
via Third Rock Ventures · filed Dec 2020 · $81M raise
Pliant TherapeuticsBoard seat
via Third Rock Ventures · filed Jul 2018 · $62.1M raise
MyokardiaBoard seat
via Third Rock Ventures · filed Apr 2015 · $46M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Third Rock Ventures
Network6
Investors connected to Charles in public investor directories — a warm-intro map.